The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance GSK reported core earnings of $1.09 per American depositary share (ADS) for second-quarter 2024, beating the Zacks Consensus Estimate of $1.00.

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow.

Earnings Estimate Revisions for Glaxo For the fiscal year ending December 2023, this drug developer is expected to earn $3.90 per share, which is a change of 12.7% from the year-ago reported number.

As we think about the sort of dynamics of making Glaxo, sorry. GSK, I just did a Wow. I'm going to have a lot of -- I'm going to have a lot of donations. That's fine. That's another, so I'm at 15 ...

Avandia: GlaxoSmithKline Cover-Up Turns Off Doctors GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. By ABC News July 13, 2010, 11:24 AM ...

GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion (1.91 billion pounds), ending on friendly terms a three-month hostile ...